476
Participants
Start Date
February 2, 2015
Primary Completion Date
December 19, 2017
Study Completion Date
May 5, 2018
DTaP-IPV combination vaccine
0.5-mL IM
DTaP vaccine and IPV vaccine
0.5-mL IM
Inje University Busan Paik Hospital, Busan
KeiMyung University Dongsan Medical Center, Daegu
Gwangmyeong Sungae Hospital, Gyeonggi-do
Wonkwang University Hospital, Iksan
Inha University Hospital, Incheon
Pusan National University Yangsan Hospital, Pusan
Asan Medical Center, Seoul
Cheil General Hospital, Seoul
Chung-Ang University Hospital, Seoul
Eulgi General Hospital, Seoul
Gangnam Sevrance Christian Hospital, Seoul
Hallym University Medical Center, Seoul
KEPCO Medical Center, Seoul
Korea Cancer Center Hospital, Seoul
KyungHee University Hospital at Gangdong, Seoul
KyungHee University Hospital, Seoul
Samsung Medical Center, Seoul
Wonju Sevrance Christian Hospital, Wŏnju
Siriraj Hospital, Bangkok
Thammasat University, Bangkok
Lead Sponsor
Boryung Pharmaceutical Co., Ltd
INDUSTRY